CB1 antagonist 1
CB1 antagonist 1 is an antagonist of CB1 receptor, used in the research of metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, gastrointestinal disorders, and cardiovascular conditions.
Product Specifications
CAS Number
[890037-68-0]
UNSPSC
12352005
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Inflammation/Immunology; Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/Benzonitrile,_3-chloro-4-[2-_4-chlorophenyl_-4-[1-_4-cyanophenyl_ethyl]-1-piperazinyl]-.html
Solubility
10 mM in DMSO
Smiles
N#CC1=CC=C(N2C(C3=CC=C(Cl)C=C3)CN(C(C4=CC=C(C#N)C=C4)C)CC2)C(Cl)=C1
Molecular Formula
C26H22Cl2N4
Molecular Weight
461.39
References & Citations
[1]Gilbert, Eric J, et al. SUBSTITUTED PIPERAZINES AS CB1 ANTAGONISTS. WO 2006060461 A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ATF6, NT (Cyclic AMP-dependent Transcription Factor ATF-6 alpha, cAMP-dependent Transcription Factor ATF-6 alpha, Activating Transcription Factor 6 alpha, ATF6-alpha, Processed Cyclic AMP-dependent Transcription Factor ATF-6 alpha)